Gliomas : Classification, Symptoms, Treatment & Prognosis

David Adamson

ISBN 10: 1631178687 / ISBN 13: 9781631178689

Edité par Nova Science Publishers Inc Jun 2014, 2014

A propos de cet article

Neuware - Gliomas represent some of the most difficult tumours to understand and most challenging to treat. As illustrated in this book, the difficulty in understanding them is apparent in various ways. They have significant diversity in histology, genomic alternations, protein expression, clinical presentation, radiographic appearance, treatment approaches, and ideas of how to cure them. Our current understanding of the genetic mutations and signalling pathways that drive these tumours has greatly expanded our knowledge and at the same time, our uncertainty about how to combat these tumours. Added to this complexity is the fact that we are typically talking about tumours that infiltrate through an organ that many of us consider the 'seat of our souls,' where we must exercise the utmost caution in how we deliver treatments with great risks. This book begins with an introduction to this complex topic with a broad overview of grading criteria, histological features, common genomic alterations and affected signalling pathways, and current treatments. Most exciting is an extensive discussion on new therapeutic concepts and delivering mechanisms that arise from the complex field of nanotechnology where nanoparticles, nanotubes, and nanocrystals may someday become the Trojan horse.

N° de réf. du vendeur 9781631178689

Détails bibliographiques

• Titre: Gliomas : Classification, Symptoms, Treatment & Prognosis
• Éditeur: Nova Science Publishers Inc Jun 2014
• Date de parution: 2014
• Langue: anglais
• ISBN à 10 chiffres: 1631178687
• ISBN à 13 chiffres: 9781631178689
• Reliure: Buch
• État de l'article: Neu
• Dimensions: 255 L x 183 H x 20 P (en millimètres) 255 millimètres de largeur par 183 millimètres de hauteur par 20 millimètres de profondeur
• Poids: 672 grammes

A propos de ce titre

Synopsis

Gliomas represent some of the most difficult tumours to understand and most challenging to treat. As illustrated in this book, the difficulty in understanding them is apparent in various ways. They have significant diversity in histology, genomic alternations, protein expression, clinical presentation, radiographic appearance, treatment approaches, and ideas of how to cure them. Our current understanding of the genetic mutations and signalling pathways that drive these tumours has greatly expanded our knowledge and at the same time, our uncertainty about how to combat these tumours. Added to this complexity is the fact that we are typically talking about tumours that infiltrate through an organ that many of us consider the "seat of our souls," where we must exercise the utmost caution in how we deliver treatments with great risks. This book begins with an introduction to this complex topic with a broad overview of grading criteria, histological features, common genomic alterations and affected signalling pathways, and current treatments. Most exciting is an extensive discussion on new therapeutic concepts and delivering mechanisms that arise from the complex field of nanotechnology where nanoparticles, nanotubes, and nanocrystals may someday become the Trojan horse.